Related Experiment Video
Updated: Jun 17, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Small Molecule Topical Ophthalmic Formulation Development-Data Driven Trends & Perspectives from Commercially
Anand Ubhe1, Heidi Oldenkamp1, Ke Wu1
1AbbVie, 2525 Dupont Drive, Irvine, CA 92612, USA.
Developing topical ophthalmic drugs requires specialized formulations for ocular conditions. This review analyzes 118 US products to guide future small molecule ophthalmic drug development.
Area of Science:
- Ophthalmology
- Pharmaceutical Sciences
- Drug Delivery
Background:
- Topical ophthalmic drug formulation is a specialized field due to unique ocular physiological conditions.
- Common formulations include solutions, suspensions, emulsions, gels, and ointments for small molecule drugs.
- Excipients and container closure systems are critical and unique for ophthalmic drug delivery.
Purpose of the Study:
- To analyze trends in marketed topical ophthalmic drug products in the US.
- To provide guidance for the development of small molecule topical ophthalmic formulations.
- To identify key factors influencing formulation and delivery system selection.
Main Methods:
- Literature review and analysis of packaging inserts from 118 US-marketed reference listed topical ophthalmic medications.
- Examination of physicochemical properties of active pharmaceutical ingredients (APIs).
- Assessment of formulation platforms, excipients, and container closure systems.
Main Results:
- The review identifies current trends in small molecule topical ophthalmic drug products available in the US.
- Analysis covers API physicochemical properties, formulation types, excipients used, and container closure systems.
- Trends provide insights into successful strategies for ophthalmic drug development.
Conclusions:
- Understanding market trends and formulation components is crucial for successful topical ophthalmic drug development.
- This analysis serves as a valuable resource for formulators developing new small molecule ophthalmic drugs.
- The study highlights the interplay between drug properties, formulation choices, and delivery systems in the ophthalmic market.
More Related Videos
07:12Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy
Published on: September 27, 2021
09:20Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes
Published on: February 8, 2018
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinical Trials: Overview
Biopharmaceutics and Pharmacokinetics: Overview
Preclinical Development: Overview